Intercede Group (IGP) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
8 Oct, 2026FY26 trading
ARR expected to grow, driven by support and maintenance revenue and further subscription-licence adoption.
FY26 revenue expected 8–9% below market expectations, reflecting US procurement delays and customer deferrals amid geopolitical uncertainty; opportunities described as delayed, not lost.
H2 FY26 order intake momentum improved, with active customer engagements continuing across the pipeline.
FY26 financial outlook
Adjusted EBITDA expected 15–18% below market expectations as lower revenue affects results alongside continued strategic investment.
Positive operating cash flow expected; year-end cash balances forecast 3–5% ahead of market expectations, with a debt-free balance sheet.
Current FY26 market consensus: revenue £18.7m, adjusted EBITDA £4.6m and cash and cash equivalents of £19.0m at 31 March 2026.
FY27 outlook
FY27 revenue target reaffirmed at £21m, with FY26 delays viewed as timing shifts rather than structural demand weakness.
Subscription transition expected to continue through FY27; delayed opportunities are expected to convert as geopolitical conditions stabilise and procurement cycles normalise.
Continued ARR growth is expected to support improved revenue performance and visibility over the medium term.
Latest events from Intercede Group
- Trading update due 8 October; H1 FY25 results expected 26 November.IGP
Trading update - H1 FY25 revenue expected up 22% YoY; period-end gross cash was £16.2m, with no debt.IGP
Trading update - Recurring revenue supported strong momentum, while gross cash rose to £18.7m with no debt.IGP
Trading update - Licence growth and c$3.2m of Q2 orders support maintained FY26 expectations.IGP
Trading update - Record FY24 results and an expanded portfolio support the ambition to double FY23 revenue.IGP
H2 2024 - Revenue rose 22%, PBT 55%, with a larger pipeline supporting FY25 expectations.IGP
H1 2025 - Recurring revenue, product expansion and global demand underpin the double-digit growth target.IGP
H2 2025 - Recurring support and new orders underpin FY26 expectations despite H1 declines.IGP
H1 2026 - Delayed federal orders landed post-year-end; £21m FY27 guidance holds as recurring revenue grows.IGP
H2 2026